RxDoctor Payments Data

Amy Lowery

Gerontology · Kings Mountain, NCNPI 1871245381

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.6% of the total across 98 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by AstraZeneca at 24.9% of the total. Among gerontology clinicians in NC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,976in general payments, 2019–2025

Across 98 payments — averaging $30.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$742
  • GSK$425
  • AbbVie$392
  • Boehringer Ingelheim$361
  • Bayer$217
  • Exact Sciences$164
  • plus $675 from 15 others

What the payments were for

  • Food & beverage$2,87697%
  • Education$1003%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,976 in reported general payments places this provider in the 90th percentile of 165 gerontology providers in North Carolina.

See all gerontology providers in North Carolina

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin28$22,607
MounjaroTirzepatide11$13,667
Breztri AerosphereBudesonide/Glycopyr/Formoterol15$11,875
FarxigaDapagliflozin Propanediol13$11,521
Trelegy ElliptaFluticasone/Umeclidin/Vilanter15$9,556
Omeprazole63$1,501
Albuterol Sulfate HfaAlbuterol Sulfate25$847
Gabapentin54$816
Pantoprazole Sodium48$725
Atorvastatin Calcium77$611
Lisinopril-HydrochlorothiazideLisinopril/Hydrochlorothiazide26$526
Amlodipine Besylate104$478
Fluticasone Propionate28$397
Lisinopril89$333
Hydrochlorothiazide65$266

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaBreztri Aerosphere, Farxiga$742$23,39528 claims
Boehringer IngelheimJardiance$361$22,60728 claims
Lilly USA, LLCMounjaro$63$13,66711 claims
GSKTrelegy Ellipta$425$9,55615 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 165 gerontology providers in North Carolina.

Other gerontology in Kings Mountain

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →